We have an epidemic of deeply flawed meta-analyses, says John Ioannidis

John Ioannidis, a professor at Stanford University and one of the most highly cited researchers in the world, has come up with some startling figures about meta-analyses. His new paper, published today in Milbank Quarterly (accompanied by this commentary), suggests that the number of systematic reviews and meta-analyses in literature have each increased by more … Continue reading We have an epidemic of deeply flawed meta-analyses, says John Ioannidis

Author objects to retraction of heart study, implies industry played role

The Journal of the American College of Cardiology (JACC) has retracted a recently published paper that questioned the effectiveness of a treatment for irregular heartbeat, against the last author’s wishes.  Andrea Natale, the study’s last and corresponding author and Executive Medical Director of Texas Cardiac Arrhythmia at Austin, took to social media today to express his frustration in the … Continue reading Author objects to retraction of heart study, implies industry played role

Anesthesia journal pulls study lacking patient consent

An anesthesia journal has retracted a paper after an author admitted that the study did not obtain appropriate consent from patients receiving a neuromuscular block in muscles on the face and hands.  The first author, Yuhji Saitoh, has the same name as a co-author of Yoshitaka Fujii, the all-time record holder with 183 retractions listed on … Continue reading Anesthesia journal pulls study lacking patient consent

Collateral damage: Paper — and editorial, and author’s response — retracted in one fell swoop

A journal has retracted the results of a clinical trial comparing strategies for bladder tumors after the authors mischaracterized the way patients were assigned to each procedure. In addition, the journal European Urology has pulled a string of correspondence between author Harry Herr at Memorial Sloan Kettering Cancer Center and an outside expert, who had questioned … Continue reading Collateral damage: Paper — and editorial, and author’s response — retracted in one fell swoop

Author loses five papers, most for “compromised” peer review

PLOS ONE has retracted three papers after the first author admitted to submitting the manuscripts without co-authors’ consent, and an investigation suggested that two out of the three papers had received faked reviews. Last August, the same author — Lishan Wang of the Shanghai Jiao Tong University — lost two more papers (one in Tumor Biology and … Continue reading Author loses five papers, most for “compromised” peer review

Weekend reads: “Research parasite” doubling down; racism in the lab; clinical trial insider trading

The week at Retraction Watch saw news of a settled lawsuit, and had us celebrating our sixth anniversary with the announcement of a new partnership. Here’s what was happening elsewhere:

You’ve been dupe’d: Nice data — let’s see them again

As we’ve said before, with hundreds of retractions per year, there are simply too many for us to cover individually. So from time to time we’ll compile a list of retractions that appeared relatively straightforward, just for record-keeping purposes. Often, these seemingly straightforward retractions involve duplications, in which authors — accidentally or on purpose — … Continue reading You’ve been dupe’d: Nice data — let’s see them again

Doctor who blew whistle on defunded study speaks

It’s rare for the U.S. government to revoke grants – but it happened recently, according to a report this week by the Kentucky Center for Investigative Reporting (KyCIR). As the report notes, in March the government revoked $914,000 in funding awarded to Susan Harkema at the University of Louisville in Kentucky, after discovering problems with a study … Continue reading Doctor who blew whistle on defunded study speaks

Crow’s feet filler study omitted pharma funding, gets retracted

A paper on a filler for eye wrinkles did not disclose that it was funded by a pharmaceutical company that produces the cosmetic. The paper explicitly noted that the authors do not have any financial conflicts of interest, and that a government program supported the study. According to the journal, a reader alerted them to the … Continue reading Crow’s feet filler study omitted pharma funding, gets retracted

Sixth retraction appears for bone researcher due to “extensive self-plagiarism”

A bone researcher in Japan has logged his sixth retraction, after acknowledging he duplicated substantial portions of a 2011 paper and added “honorary” co-authors. The retraction, in Parkinsonism & Related Disorders, follows five others for Yoshihiro Sato, including one from JAMA, some of which were pulled over concerns regarding authorship and data integrity. The latest retraction duplicated … Continue reading Sixth retraction appears for bone researcher due to “extensive self-plagiarism”